Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ji Z et al. | [The role of platelet activating factor in mesenterioangial microcirculatory disturbance complicated with acute pancreatitis in rats]. | 1995 | Zhonghua Yi Xue Za Zhi | pmid:7780816 |
Ma X et al. | [Corneal epithelial wound healing is delayed by platelet activating factor treatment]. | 2004 | Zhonghua Yan Ke Za Zhi | pmid:15307983 |
Qin X et al. | [The effect of platelet-activating factor antagonists on early bacteria translocation of rat after burn injury]. | 1995 | Zhonghua Wai Ke Za Zhi | pmid:7587673 |
Ji Z et al. | [The role of platelet activating factor in pathogenesis of acute pancreatitis in dogs]. | 1997 | Zhonghua Wai Ke Za Zhi | pmid:10374489 |
Xiao J et al. | [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. | 1995 | Zhonghua Wai Ke Za Zhi | pmid:8762548 |
Yu P et al. | [The roles of platelet activating factor in intestinal mucosal barrier injury after burn]. | 1995 | Zhonghua Wai Ke Za Zhi | pmid:8565724 |
Han E et al. | [Effect of chronic antiplatelet treatment on platelet activating factor-induced platelet activity in stroke]. | 1991 | Zhonghua Shen Jing Jing Shen Ke Za Zhi | pmid:1868762 |
Yu HP et al. | [Experimental and clinical study of activated platelet in allergic asthma]. | 1991 | Zhonghua Nei Ke Za Zhi | pmid:1806336 |
Shi H et al. | [Effects of a platelet-activating factor antagonist ONO-6240 on antigen induced eosinophil infiltration into the airways]. | 1995 | Zhonghua Nei Ke Za Zhi | pmid:8731847 |
Ren G and Ye R | [Changes in urinary excretion of platelet activating factor and its significance in patients with primary nephrotic syndrome]. | 1996 | Zhonghua Nei Ke Za Zhi | pmid:9275622 |